Use of a high-frequency linear transducer and MTI filtered color flow mapping in the assessment of fetal heart anatomy at the routine 11 to 13 + 6-week scan: A randomized trial

Ultrasound in Obstetrics and Gynecology

Volumn 39, Issue 2, 2012, Pages 145-151

  Votino, C ^a,b   Kacem, Y ^a   Dobrescu, O ^a   Dessy, H ^c   Cos, T ^a   Foulon, W ^b   Jani, J ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

congenital heart disease; fetal heart; first trimester; high frequency; moving target indicator filtered color flow mapping

Indexed keywords

ARTICLE; BLOOD FLOW VELOCITY; BODY MASS; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FETUS HEART; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HISTOLOGY; HUMAN; IMAGE ENHANCEMENT; INSTRUMENTATION; PLACENTA; PREGNANCY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

BLOOD FLOW VELOCITY; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; FETAL HEART; GESTATIONAL AGE; HUMANS; IMAGE ENHANCEMENT; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84856337598     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.9015     Document Type: Article

References (21)

1. Hoffman JI,. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol 1995; 16: 103-113.
2. Hoffman J, Kaplan S,. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900. (Pubitemid 34628268)
3. Bonnet D, Coltri A, Butera G, Fermont L, Le Bidois J, Kachaner J, Sidi D,. Detection of trasposition of great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99: 916-918. (Pubitemid 29094306)
4. Tworetzky W, McElhinney DB, Reddy MV, Brook MM, Hanley FM, Silverman NH,. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103: 1269-1273. (Pubitemid 32221351)
5. Franklin O, Burch M, Manning N, Sleeman K, Gould S, Archer N,. Prenatal diagnois of coarctation of the aorta improves survival and reduces morbidity. Heart 2002; 87: 67-69. (Pubitemid 34074958)
6. Johnson B, Simpson LL,. Screening for congenital heart disease: a move toward earlier echocardiography. Am J Perinatol 2007; 24: 449-456. (Pubitemid 47536005)
7. Yagel S, Cohen SM, Messing B,. First and early second trimester fetal heart screening. Curr Opin Obstet Gynecol 2007; 19: 183-190. (Pubitemid 46412108)
8. Rasiah SV, Publicover M, Ewer AK, Khan KS, Kilby MD, Zamora J,. A systematic review of the accuracy of first-trimester ultrasound examination for detecting major congenital heart disease. Ultrasound Obstet Gynecol 2006; 28: 110-116. (Pubitemid 44133462)
9. Smrcek JM, Berg C, Geipel A, Fimmers R, Axt-Fliedner R, Diedrich K, Gembruch U,. Detection rate of early fetal echocardiography and in utero development of congenital heart defects. J Ultrasound Med 2006; 25: 187-196. (Pubitemid 43214432)
10. Lombardi CM, Bellotti M, Fesslova V, Cappellini A,. Fetal echocardiography at the time of the nuchal translucency scan. Ultrasound Obstet Gynecol 2007; 29: 249-257. (Pubitemid 46447306)
11. Persico N, Moratalla J, Lombardi CM, Zidere V, Allan L, Nicolaides KH,. Fetal echocardiography at 11-13 weeks by transabdominal high-frequency ultrasound. Ultrasound Obstet Gynecol 2011; 37: 296-301.
12. Achiron R, Tadmor O,. Screening for fetal anomalies during the first trimester of pregnancy: transvaginal versus transabdominal sonography. Ultrasound Obstet Gynecol 1991; 1: 186-191.
13. Souka AP, Pilalis A, Kavalakis Y, Kosmas Y, Antsaklis P, Antsaklis A,. Assessment of fetal anatomy at the 11-14-week ultrasound examination. Ultrasound Obstet Gynecol 2004; 24: 730-733.
14. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH,. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002; 20: 22-29. (Pubitemid 34748245)
15. Gembruch U, Shi C, Smreck JM,. Biometry of the fetal heart between 10 and 17 weeks of gestation. Fetal Diagn Ther 2000; 15: 20-31. (Pubitemid 30133148)
16. Ebrashy A, El Kateb A, Momtaz M, El Sheikhah A, Aboulghar MM, Ibrahim M, Saad M,. 13-14-week fetal anatomy scan: a 5-year prospective study. Ultrasound Obstet Gynecol 2010; 35: 292-296.
17. Atzei A, Gajewska K, Huggon IC, Allan L, Nicolaides KH,. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005; 26: 154-157. (Pubitemid 41540299)
18. Simpson LL, Malone FD, Bianchi DW, Ball RH, Nyberg DA, Comstock CH, Saade G, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, D'Alton ME,. Nuchal translucency and the risk of congenital heart disease. Obstet Gynecol 2007; 109: 376-383. (Pubitemid 46197431)
19. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K,. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2008; 31: 256-260.
20. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH,. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 27: 151-155. (Pubitemid 43733729)
21. Borenstein M, Cavoretto P, Allan L, Huggon I, Nicolaides KH,. Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetuses. Ultrasound Obstet Gynecol 2008; 31: 20-24. (Pubitemid 351211926)